CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Bruce Culleton

Chief Executive Officer, ProKidney

Search every verified Bruce Culleton interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Bruce Culleton, M.D., CEO of ProKidney, discussed the company’s work in chronic kidney disease (CKD) on the Business of Biotech podcast. He described ProKidney as a late-stage autologous cell therapy company aiming to delay or eliminate the need for dialysis by preserving kidney function, with its lead candidate, renelparin cell, in phase three clinical trials. Culleton noted that the company received FDA Regenerative Medicine Advanced Therapy (RMAT) designation and that a strategic tradeoff in mid-2024, made before his tenure, involved consolidating two phase three studies. He also highlighted that most of the over 30 million US patients with kidney disease are unaware of their condition, and he identified screening and awareness as the greatest opportunity to help them, noting that kidney function can be checked with simple urine and blood tests. Culleton also discussed his career transition from academic research and an associate professorship to industry, crediting a key mentor with influencing his path. He explained that ProKidney’s therapy involves taking a patient’s cells, processing them into billions of cells, and injecting them back into the kidney under CT guidance, which he said helps the patient’s innate repair mechanisms and has shown a stabilization of kidney function clinically. He additionally commented on kidney donation, stating that while donors undergo rigorous assessment, the emotional benefits of helping a loved one outweigh the small clinical risks.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →